Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-14-005801
Filing Date
2014-08-14
Accepted
2014-08-14 10:30:55
Documents
9
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0614_immudyne.htm 10-Q 290755
2 CERTIFICATION f10q0614ex31i_immudyne.htm EX-31.1 8133
3 CERTIFICATIONS f10q0614ex32i_immudyne.htm EX-32.1 3154
  Complete submission text file 0001213900-14-005801.txt   2388152

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE immd-20140630.xml EX-101.INS 266489
5 XBRL SCHEMA FILE immd-20140630.xsd EX-101.SCH 28604
6 XBRL CALCULATION FILE immd-20140630_cal.xml EX-101.CAL 27980
7 XBRL DEFINITION FILE immd-20140630_def.xml EX-101.DEF 59861
8 XBRL LABEL FILE immd-20140630_lab.xml EX-101.LAB 216576
9 XBRL PRESENTATION FILE immd-20140630_pre.xml EX-101.PRE 145977
Mailing Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549
Business Address 50 SPRING MEADOW ROAD MT. KISCO NY 10549 (914) 244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

EIN.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-184487 | Film No.: 141040183
SIC: 2833 Medicinal Chemicals & Botanical Products